Ann D Cohen, PhD
Associate Professor of Psychiatry at the University of Pittsburgh

Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is also the Director of the Neuroimaging Core of the University of Pittsburgh Alzheimer’s Disease Research Center and the co-Director of the Molecular Biomarkers in Psychiatry Program.

Dr. Cohen is also the lead of the recruitment team on the Alzheimer’s disease Biomarker Consortium- Down Syndrome (ABC-DS) and is the PI of multiple NIA funded studies focusing on neuroimaging in aging and Alzheimer’s disease.

Dr. Cohen earned her PhD in Neuroscience from the University of Pittsburgh in 2006 and completed a postdoctoral fellowship at Western Psychiatric Institute and Clinic at UPMC in 2011.

Dr. Cohen served as a steering committee member for the Neuroimaging Professional Interest area of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) from 2015 to 2019 and is a member of the ISTAART advisory council.

Her primary research interests focus on PET imaging to explore early detection of amyloid in Alzheimer’s disease using the amyloid imaging agent Pittsburgh-compound B and the relationship of lifestyle factors to Alzheimer’s disease pathology.

Participación
3rd June - 10:25 h.
Integrating standard and novel MRI measures to measure neurodegeneration and cerebrovascular disease across the spectrum of AD - SPEAKER